RTTNews | Sep 29, 2020 10:51AM EDT

10:50 Tuesday, September 29, 2020 (RTTNews.com) - Shares of nano-cap company Adial Pharmaceuticals, Inc. (ADIL) surged nearly 40% on Tuesday morning after FDA granted emergency use authorization for the company's COVID-19 point-of-care antibody test.

ADIL is currently trading at $1.9542, up $0.5442 or 38.5958%, on the Nasdaq.

The clinical-stage biopharmaceutical company said FDA has issued an emergency use authorization for its Assure/FaStep COVID-19 IgG/IgM Rapid Test Device.

This marks the first FDA EUA for a serology (antibody) point-of-care test for COVID-19 using fingerstick blood samples as compared with current approved tests that only utilize serum, plasma, or a venous blood draw.

Read the original article on RTTNews ( https://www.rttnews.com/3132297/stock-alert-adial-pharma-jumps-40-as-fda-grants-eua-for-covid-19-test.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved